ArticleFrontiers in pharmacology2024

A phase I, randomized study to evaluate the safety, tolerability, and pharmacokinetics of mefunidone in healthy subjects.

Mai Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.